[Patient-oriented healthcare programs. Concepts and practical experience in the field of chronic heart failure].
Disease management programs (DMP) have been recently introduced in the German statutory healthcare sector by federal law. These compulsory programs are aimed at enhancing guideline-based treatment by primary care physicians. Based on a systematic analysis of disease models and deficits in healthcare delivery, patient-oriented DMP offer an alternative approach. Their standardized services include care calls, written educational material, reminder systems, health reports, and optional telemetric monitoring. As an example of this approach, the medical results of 151 patients participating in a comprehensive chronic heart failure (CHF) program were evaluated. Within the observation period of 12 months, the number of patients receiving appropriate prescriptions (ACE inhibitors, diuretics, or beta blockers) rose significantly. In many patients there was a remission of CHF key symptoms (leg edema, shortness of breath, dizziness). The daily weight monitoring was particularly appreciated by the patients. For further development of patient-oriented DMP in the German healthcare system, it will be crucial that financial savings can be convincingly demonstrated besides the clinical benefits. These include quality of life, particularly for those chronic conditions in which patient self-management has a large impact on disease course.
ArztPartner almeda AG, München.
Dieter J
DJ
Ziegenhagen
Christian
C
Frye
Stefan
S
Kottmair
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003695:Delivery of Health Care / Q000592:standards; D004232:Diuretics / Q000627:therapeutic use; D005858:Germany; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008954:Models, Biological; D010358:Patient Participation; D018802:Patient-Centered Care / Q000592:standards*; D011785:Quality Assurance, Health Care
D000317:Adrenergic alpha-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics